Bernardo Cortese, MD
-
Specialty: Cardiology
View Expertise -
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: English, French, Italian
Office Locations
UH Cleveland Medical Center Mather (0 mi.)
11100 Euclid Ave
Mather Ste 1800
Cleveland, OH 44106
216-844-3800
UH Cleveland Minoff Health Center (7 mi.)
3909 Orange Pl
Ste 3300
Beachwood, OH 44122
216-844-3800
UH Lake West Willoughby Medical Office Building (12 mi.)
36100 Euclid Ave
Ste 120
Willoughby, OH 44094
440-951-8360
Biography: Bernardo Cortese, MD
Expertise
Education
Fellowship | Structural and Peripheral Angioplasty
Structural and Peripheral Angioplasty - Scuola Superiore Sant'anna (2016 - 2017)
Residency | Cardiology
Cardiology - Community Hospital East (2001 - 2005)
Medical Education
Universita Di Pisa, Segreteria Studenti, Dipartimento 1--Didattica E Ricerca (2001)
About
Bernardo Cortese, MD, FESC, FSCAI, is an internationally renowned interventional cardiologist specializing in the diagnosis and treatment of complex coronary artery disease and chronic total occlusions. He is Co-Director of the Coronary Center at University Hospitals Harrington Heart & Vascular Institute and Professor of Medicine at Case Western Reserve University School of Medicine.
Dr. Cortese earned his medical degree from the University of Pisa in Pisa, Italy. His postdoctoral training began with internships at various European and American hospitals. He then completed a cardiology fellowship at the University of Pisa followed by an interventional cardiology master program at Sant’Anna University in Pisa, Italy. Dr. Cortese has steadily honed his skills as an interventional cardiologist with numerous advanced certifications in carotid, coronary, peripheral artery, and structural heart techniques.
Prior to joining University Hospitals in August 2024, Dr. Cortese served as Director of Cardiology at San Carlo Multispecialty Clinic in Milano, Italy, and consultant interventional cardiologist for coronary and structural heart disease at Columbus Clinic and Fatebenefratelli Hospital in Milano, Italy. He was also President of the Scientific Committee for the Cardiovascular Research and Innovation Foundation and Chief Executive Officer of DCB Academy, a research and education institute that promotes lectures, research and publications on interventional cardiology-related topics.
Dr. Cortese is an avid physician-researcher with leading investigator roles in more than 60 clinical trials for novel cardiovascular therapies and techniques. He is also a highly sought educator, with active proctorships in complex coronary artery disease percutaneous coronary interventions (PCI) in Bangladesh, Thailand, Malaysia, Singapore, Indonesia, United Arab Emirates, Poland, Czeck Republic, Austria, Croatia, Serbia, Spain, and Brazil.
Dr. Cortese is a widely published interventional cardiology expert, with over 340 articles in peer-reviewed medical journals. In addition, he serves as reviewer and editorial board member for multiple international journals, including JACC Cardiovascular Interventions, Catheterization and Cardiovascular Interventions, Cardiovascular Revascularization Medicine, Eurointervention, Journal of the Society for Cardiovascular Angiography & Interventions (SCAI), New England Journal of Medicine, American Journal of Cardiology, Circulation, Minerva Cardiology and Angiology, Circulation-Cardiovascular Interventions, The Lancet and American Journal of Cardiovascular Drugs.
Dr. Cortese is recognized as a fellow of the European Society of Cardiology (FESC), Society of Cardiovascular Angiography & Interventions (FSCAI), and the Indo-European Course of Revascularization (FIECR). He has served as Coordinator of the International Fellowship Program recognized by the European Society of Cardiology in Milano, Italy since 2013.
Dr. Cortese has extensive experience in the management of patients with multivessel coronary artery disease, chronic total occlusion and cardiogenic shock. He continues to dedicate his career to the care of sick and fragile patients, as well as the development and optimization of innovative therapies in the field of cardiovascular medicine.
Research & Publications
Research Links
PubMed
View Research
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Bernardo Cortese did not disclose any Outside Relationships with Industry.